New study shows nexalin's deep intracranial frequency stimulation (difs) significantly improves memory and cognitive function in alzheimer's patients

Groundbreaking trial reveals difs increases neural activity and blood flow in the hippocampus, offering hope for alzheimer's treatment groundbreaking trial reveals difs increases neural activity and blood flow in the hippocampus, offering hope for alzheimer's treatment
NXL Ratings Summary
NXL Quant Ranking